We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
-17.81%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$454M
AUM Growth
-$113M
Cap. Flow
+$442M
Cap. Flow %
97.29%
Top 10 Hldgs %
43.03%
Holding
80
New
1
Increased
58
Reduced
12
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 29.65%
2 Technology 19.55%
3 Financials 11.41%
4 Consumer Discretionary 8.8%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
26
Duke Energy
DUK
$96.2B
$7.58M 1.67%
70,053
+2,685
+4% +$295K
AMGN icon
27
Amgen
AMGN
$221B
$7.1M 1.56%
28,972
+1,260
+5% +$309K
ADP icon
28
Automatic Data Processing
ADP
$107B
$7.09M 1.56%
33,757
+1,635
+5% +$358K
VZ icon
29
Verizon
VZ
$193B
$6.73M 1.48%
132,578
+5,864
+5% +$297K
TFC icon
30
Truist Financial
TFC
$64.6B
$6.73M 1.48%
140,462
+7,841
+6% +$387K
ITW icon
31
Illinois Tool Works
ITW
$85.5B
$6.03M 1.33%
33,095
+1,870
+6% +$374K
NVDA icon
32
NVIDIA
NVDA
$5.31T
$5.67M 1.25%
373,990
+5,930
+2% +$112K
TEAM icon
33
Atlassian
TEAM
$28.8B
$5.33M 1.17%
28,417
+457
+2% +$97.6K
SPG icon
34
Simon Property Group
SPG
$72.9B
$5.24M 1.15%
55,163
+4,163
+8% +$477K
MMM icon
35
3M
MMM
$93.9B
$5.23M 1.15%
47,775
+2,703
+6% +$327K
VFC icon
36
VF Corp
VFC
$5.98B
$4.26M 0.94%
96,425
+6,890
+8% +$346K
EXAS
37
DELISTED
Exact Sciences
EXAS
$4.24M 0.93%
107,598
+2,705
+3% +$145K
SWAV
38
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$4.12M 0.91%
21,533
+3,140
+17% +$554K
SBUX icon
39
Starbucks
SBUX
$121B
$3.96M 0.87%
51,906
+1,590
+3% +$122K
FANG icon
40
Diamondback Energy
FANG
$52.1B
$3.49M 0.77%
28,810
+675
+2% +$92.5K
MRNA icon
41
Moderna
MRNA
$22.5B
$3.36M 0.74%
23,542
+330
+1% +$47.2K
BA icon
42
Boeing
BA
$190B
$2.86M 0.63%
20,941
+403
+2% +$59.4K
ZTS icon
43
Zoetis
ZTS
$31.2B
$2.72M 0.6%
15,813
+440
+3% +$76.1K
IYE icon
44
iShares US Energy ETF
IYE
$1.7B
$1.49M 0.33%
39,025
+1,245
+3% +$52.9K
IWF icon
45
iShares Russell 1000 Growth ETF
IWF
$127B
$1.44M 0.32%
26,348
+1,904
+8% +$114K
MTUM icon
46
iShares MSCI USA Momentum Factor ETF
MTUM
$26.3B
$1.35M 0.3%
9,874
+808
+9% +$119K
IWP icon
47
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
$1.28M 0.28%
16,179
+1,439
+10% +$125K
DWAS icon
48
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$450M
$1.27M 0.28%
18,737
+1,136
+6% +$89K
RSP icon
49
Invesco S&P 500 Equal Weight ETF
RSP
$99.3B
$1.25M 0.28%
9,345
+380
+4% +$55.6K
REGL icon
50
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.81B
$1.18M 0.26%
17,519
+775
+5% +$54.3K

Similar funds

Biondo Investment Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Biondo Investment Advisors held 80 positions worth $454M, down 20% from $568M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Biondo Investment Advisors deployed $442M of net new capital in Q2 2022, opening 1 new position and adding to 58 existing holdings. Its largest new stake was Wells Fargo: 16,388 shares worth $643K.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bed Bath & Beyond Inc, an estimated $3.4M trimmed.

  • Biondo Investment Advisors's largest Q2 2022 buy was Wells Fargo: 16,388 shares worth $643K.
  • Biondo Investment Advisors added most to Alphabet (Google) Class A in Q2 2022, an estimated $437M increase.
  • Biondo Investment Advisors's biggest Q2 2022 reduction was Bed Bath & Beyond Inc, cutting an estimated $3.4M.
  • Biondo Investment Advisors fully exited BioCryst Pharmaceuticals in Q2 2022, selling an estimated $4.25M.
  • Biondo Investment Advisors's ten largest holdings make up 43% of its $454M portfolio in Q2 2022.
  • Biondo Investment Advisors opened 1 new position and closed 4 in Q2 2022.
  • Biondo Investment Advisors's portfolio value fell 20% quarter-over-quarter to $454M.

Based on Biondo Investment Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.